Equities

Cosmos Pharmaceutical Corp

Cosmos Pharmaceutical Corp

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (JPY)7,015.00
  • Today's Change-105.00 / -1.47%
  • Shares traded250.30k
  • 1 Year change-10.84%
  • Beta0.0980
Data delayed at least 20 minutes, as of Nov 14 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of May 31 2024202420232022
ASSETS
Cash And Short Term Investments52,30145,92837,362
Total Receivables, Net12,19910,2218,577
Total Inventory86,17377,47966,363
Prepaid expenses2,5682,4292,189
Other current assets, total1,0921,028980
Total current assets154,333137,085115,471
Property, plant & equipment, net295,798259,464225,286
Goodwill, net------
Intangibles, net497547433
Long term investments4.004.004.00
Note receivable - long term------
Other long term assets23,45321,59919,892
Total assets476,546420,967363,052
LIABILITIES
Accounts payable179,549161,852139,224
Accrued expenses10,0838,5166,456
Notes payable/short-term debt000
Current portion long-term debt/capital leases6,5124,4853,056
Other current liabilities, total17,08517,20013,327
Total current liabilities213,229192,053162,063
Total long term debt27,55113,7166,357
Total debt34,06318,2019,413
Deferred income tax------
Minority interest------
Other liabilities, total4,3244,1264,125
Total liabilities245,104209,895172,545
SHAREHOLDERS EQUITY
Common stock4,1784,1784,178
Additional paid-in capital5,1014,6104,610
Retained earnings (accumulated deficit)222,284202,485181,954
Treasury stock - common(225)(242)(241)
Unrealized gain (loss)1.001.001.00
Other equity, total103405.00
Total equity231,442211,072190,507
Total liabilities & shareholders' equity476,546420,967363,052
Total common shares outstanding797979
Treasury shares - common primary issue0.740.800.80
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.